Search results
Moderna Litigation Against BioNTech and Pfizer Stayed Pending IPR | JD Supra
JD Supra· 2 weeks agoWe previously reported on the litigation brought by ModernaTX, Inc. and Moderna US, Inc. (collectively, “Moderna”) against BioNTech SE, BioNTech...
BioNTech (BNTX) to Report Q1 Earnings: Is a Beat in Store?
Zacks via Yahoo Finance· 2 weeks agoOn BioNTech's (BNTX) first-quarter 2024 earnings call, investors' focus is likely to be on the...
BioNTech Lifts As Covid Sales Plummet With 90% Of Revenue Still To Come
Investor's Business Daily· 1 week agoSales of Comirnaty, the BioNTech-Pfizer-partnered Covid shot, plummeted 86% to $202 million,...
Pfizer (PFE) Q1 Earnings & Sales Top, EPS Guidance Raised
Zacks via Yahoo Finance· 2 weeks agoThe revenue decline, as expected, was due to a steep drop in revenues from its COVID-19 products,...
What's Going With BioNTech Stock On Monday?
Benzinga· 1 week agoMonday, BioNTech SE BNTX reported a first-quarter EPS loss of 1.31 euros ($1.41 loss), a shift from an income of 2.05 euros, missing the consensus loss...
Pfizer lifts profit view on cost cuts, demand for COVID products
Reuters· 2 weeks ago, opens new tab lifted its annual earnings forecast on Wednesdayand reported a first-quarter profit...
Pfizer Stock Is Near An 11-Year Low — But Is It A Buy On This 'Massive' Upside?
Investor's Business Daily· 6 days agoSo, all in all, is PFE stock a buy or a sell right now? Pfizer Stock Fundamentals: 'Massive' Upside...
Pfizer Jumps On 'Massive' First-Quarter Upside Thanks To Paxlovid Surprise
Investor's Business Daily· 2 weeks agoPfizer stock surged Wednesday after the pharma giant walloped analysts' first-quarter earnings...
BioNTech shares dip 2% on earnings and revenue miss By Investing.com
Investing.com· 1 week agoShares of BioNTech SE (NASDAQ:BNTX) fell 2.2% following the announcement of the first quarter...
Novavax strikes $1.2B deal with Sanofi to develop COVID-flu combo vaccine
BenefitsPRO· 14 hours agoNovavax signed a $1.2 billion licensing agreement with Sanofi that includes commercializing a...